Regulatory t cells and pulmonary hypertension

Trends in Cardiovascular Medicine

Volumn 21, Issue 6, 2011, Pages 166-171

  Tamosiuniene, Rasa ^a   Nicolls, Mark R ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD VESSEL INJURY; ENDOTHELIUM CELL; HUMAN; IMMUNE DYSREGULATION; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RECEPTOR INTRINSIC ACTIVITY; REGULATORY T LYMPHOCYTE; REVIEW; RISK FACTOR;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION; RATS; RATS, NUDE; T-LYMPHOCYTES, REGULATORY; VASCULAR SYSTEM INJURIES;

EID: 84863872288     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.05.004     Document Type: Review

References (47)

1. - cells with tolerogenic properties. Transplantation 2007, 83:474-484.
2. Atkinson C., Stewart S., Upton P.D., et al. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 2002, 105:1672-1678.
3. Austin E.D., Rock M.T., Mosse C.A., et al. T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension. Respir Med 2010, 104:454-462.
4. + T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer. J Immunol 2006, 177:1460-1469.
5. Cao Y., Szabolcs A., Dutta S.K., et al. Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype. J Biol Chem 2010, 285:31840-31848.
6. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
7. Clark A.N., Youkey R., Liu X., et al. A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes. Circ Res 2007, 101:1130-1138.
8. Dorfmüller P., Chaumais M.C., Giannakouli M., et al. Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension. Respir Res 2011, 12:119.
9. Facciabene A., Peng X., Hagemann I.S., et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature 2011, 475:226-230.
10. Fujita M., Shannon J.M., Irvin C.G., et al. Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2001, 280:L39-L49.
11. + T cells. Blood 2007, 109:2058-2065.
12. Ghiringhelli F., Ménard C., Martin F., Zitvogel L. The role of regulatory T cells in the control of natural killer cells: Relevance during tumor progression. Immunol Rev 2006, 214:229-238.
13. Gomez-Arroyo J.G., Farkas L., Alhussaini A.A., et al. The monocrotaline model of pulmonary hypertension in perspective. Am J Physiol Lung Cell Mol Physiol 2012, 302:L363-L369.
14. Hall S., Brogan P., Haworth S.G., Klein N. Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children. Thorax 2009, 64:778-783.
15. + T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3. J Immunol 2006, 177:7820-7832.
16. Hong K.H., Lee Y.J., Lee E., et al. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension. Circulation 2008, 118:722-730.
17. Kim J.M., Rasmussen J.P., Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007, 8:191-197.
18. + T cells in mice. Immunol Cell Biol 2011, 89:130-142.
19. + regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol 2006, 17:2731-2741.
20. McKinley L., Logar A.J., McAllister F., et al. Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia. J Immunol 2006, 177:6215-6226.
21. Miyata M., Sakuma F., Ito M., et al. Athymic nude rats develop severe pulmonary hypertension following monocrotaline administration. Int Arch Allergy Immunol 2000, 121:246-252.
22. high regulatory T cells that mediate type V collagen-induced tolerance to lung allografts. J Immunol 2003, 171:1140-1147.
23. Montagnoli C., Fallarino F., Gaziano R., et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J Immunol 2006, 176:1712-1723.
24. + regulatory T cells control innate immune reactivity after injury. J Immunol 2005, 174:2957-2963.
25. Newman J.H., Wheeler L., Lane K.B., et al. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med 2001, 345:319-324.
26. Nicolls M.R., Taraseviciene-Stewart L., Rai P.R., et al. Autoimmunity and pulmonary hypertension: A perspective. Eur Respir J 2005, 26:1110-1118.
27. + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci U S A 2008, 105:10113-10118.
28. Ormiston M.L., Deng Y., Stewart D.J., Courtman D.W. Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension. Am J Respir Cell Mol Biol 2010, 43:546-554.
29. Price L.C., Montani D., Tcherakian C., et al. Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats. Eur Respir J 2011, 37:813-822.
30. Raval C.M., Lee P.J. Heme oxygenase-1 in lung disease. Curr Drug Targets 2010, 11:1532-1540.
31. Rolstad B. The athymic nude rat: An animal experimental model to reveal novel aspects of innate immune responses?. Immunol Rev 2001, 184:136-144.
32. +regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
33. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
34. Sarris M., Andersen K.G., Randow F., et al. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 2008, 28:402-413.
35. Shetty S., Weston C.J., Oo Y.H., et al. Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium. J Immunol 2011, 186:4147-4155.
36. + T regulatory cells. J Exp Med 2004, 199:323-335.
37. Steiner M.K., Syrkina O.L., Kolliputi N., et al. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 2009, 104:236-244.
38. + regulatory T cells. Hum Immunol 2005, 66:222-230.
39. Takamatsu H., Takegahara N., Nakagawa Y., et al. Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Nat Immunol 2010, 11:594-600.
40. Tamosiuniene R., Tian W., Dhillon G., et al. Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension. Circ Res 2011, 109:867-879.
41. Taraseviciene-Stewart L., Nicolls M.R., Kraskauskas D., et al. Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling. Am J Respir Crit Care Med 2007, 175:1280-1289.
42. + regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A 2007, 104:19446-19451.
43. +cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension. Respiration 2008, 75:272-280.
44. Vergadi E., Chang M.S., Lee C., et al. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension. Circulation 2011, 123:1986-1995.
45. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532.
46. Wang Y., Liu H., McKenzie G., et al. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 2010, 16:279-285.
47. Workman C.J., Cauley L.S., Kim I.J., et al. Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo. J Immunol 2004, 172:5450-5455.